[Federal Register Volume 79, Number 195 (Wednesday, October 8, 2014)]
[Notices]
[Page 60865]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-24018]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Austin 
Pharma, LLC

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Austin Pharma, LLC applied to be registered as a manufacturer 
of certain basic classes of controlled substances. The DEA grants 
Austin Pharma, LLC registration as a manufacturer of those controlled 
substances.

SUPPLEMENTARY INFORMATION: By notice dated May 28, 2014, and published 
in the Federal Register on June 4, 2014, 79 FR 32322, Austin Pharma, 
LLC, 811 Paloma Drive, Suite C, Round Rock, Texas 78665-2402, applied 
to be registered as a manufacturer of certain basic classes of 
controlled substances. No comments or objections were submitted to this 
notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823(a) and determined that the registration of 
Austin Pharma, LLC to manufacture the basic classes of controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Tetrahydrocannabinols (7370)...............  I
------------------------------------------------------------------------

    The company plans to manufacture bulk synthetic active 
pharmaceutical ingredients (APIs) for distribution and new product 
development to its customers. The company plans to bulk manufacture a 
synthetic tetrahydrocannabinol.
    In reference to drug code 7360, the company plans to manufacture a 
synthetic cannabinol in bulk for sale to its customers. The controlled 
substance will be further synthesized to bulk manufacture a synthetic 
tetrahydrocannabinol (7370). No other activity for this drug code is 
authorized for this registration.

    Dated: October 2, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-24018 Filed 10-7-14; 8:45 am]
BILLING CODE 4410-09-P